# The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study

Study · id `cardio:ct-nct03170349` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03170349](<https://clinicaltrials.gov/study/NCT03170349>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03170349

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

## Technical summary

Registry record NCT03170349. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-27 (actual); primary completion 2020-07-30 (actual). Results posted on 2021-12-01.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 124 participants (enrolled count; ClinicalTrials.gov record NCT03170349, source copy `cardio:ctgov-nct03170349-2026-02-05`, retrieved 2026-10-26)
- Started: 2017-06-27 (actual) (ClinicalTrials.gov record NCT03170349, source copy `cardio:ctgov-nct03170349-2026-02-05`, retrieved 2026-10-26)
- Primary completion: 2020-07-30 (actual) (ClinicalTrials.gov record NCT03170349, source copy `cardio:ctgov-nct03170349-2026-02-05`, retrieved 2026-10-26)
- Completion: 2025-05-27 (actual) (ClinicalTrials.gov record NCT03170349, source copy `cardio:ctgov-nct03170349-2026-02-05`, retrieved 2026-10-26)
- Results first posted: 2021-12-01 (ClinicalTrials.gov record NCT03170349, source copy `cardio:ctgov-nct03170349-2026-02-05`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; Germany; Greece; Italy; Switzerland (ClinicalTrials.gov record NCT03170349, source copy `cardio:ctgov-nct03170349-2026-02-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03170349-2026-02-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
- Acronym: CLASP
- Condition: Mitral Valve Regurgitation
- Intervention (Device): Mitral Valve Repair
- Lead sponsor: Edwards Lifesciences
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Edwards Lifesciences (`cardio:edwards-lifesciences`)

## Provenance

Content hash: dc9b6ffd4557fcf8758c3708434a234cd2a697943715499b8b67dd0825fe0083
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
